PURIFICATION AND ACTIVITY OFTHE CHIMERIC SEPTU ANTI-VIRAL DEFENSE SYSTEM

Marija Duchovskyte1, Dalia Smalakyte1, Gintautas Tamulaitis1

1 Institute of Biotechnology, Life Sciences Center, Vilnius University, Lithuania

In order to withstand frequent bacteriophages’ attacks, prokaryotes have developed multiple sophisticated defense mechanisms. For instance, CRISPR-Cas provides immunity to bacteria and archaea by recalling past phage infections, and restriction-modification (RM) systems target specific viral genomic sequences [1]. Given the enormous diversity of viruses, it is likely that more different bacterial defense systems exist than previously described [2]. Over the past few years, systematic analyses of prokaryotic genomes followed by experimental validation have uncovered numerous previously unknown anti-phage defense systems [3]. Here, we focus on a recently discovered anti-viral defense system called Septu.

The Septu defense system operates using two proteins: putative ATPase PtuA and HNH nuclease PtuB [3]. In previous experiments, we were unable to purify both the ATPase and the nuclease belonging to the same Septu system from B. thuringiensis or B. weihenstephanensis. Thus, in this study we present the chimeric Septu system composed of B. thuringiensis PtuA and B. weihenstephanensis PtuB. We evaluated its activity against E. coli phages and tested various nucleic acids as substrates in vitro.


[1] H. G. Hampton, et al. The arms race between bacteria and their phage foes. Nature 577, 327-336 (2020)

[2] L. Gao, et al. Diverse enzymatic activities mediate antiviral immunity in prokaryotes. Science 369(6507), 1077-1084 (2020)

[3] S. Doron, et al. Systematic discovery of antiphage defense systems in the microbial pangenome. Science 359(6379) (2018)